LiCl induces TNF-α and FasL production, thereby stimulating apoptosis in cancer cells

BACKGROUND: The incidence of cancer in patients with neurological diseases, who have been treated with LiCl, is below average. LiCl is a well-established inhibitor of Glycogen synthase kinase-3, a kinase that controls several cellular processes, among which is the degradation of the tumour suppresso...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Larissa, Marinescu, Gabriela, Nazarenko, Irina, Thiele, Wilko, Oberle, Carolin, Sleeman, Jonathan, Blattner, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115922/
https://www.ncbi.nlm.nih.gov/pubmed/21609428
http://dx.doi.org/10.1186/1478-811X-9-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115922/
https://www.ncbi.nlm.nih.gov/pubmed/21609428
http://dx.doi.org/10.1186/1478-811X-9-15

Ejemplares similares